Central retinal vein occlusion in the setting of fibroblast growth factor receptor inhibition

PURPOSE: To report a case of central retinal vein occlusion (CRVO) in a patient being treated with a fibroblast growth factor receptor (FGFR) inhibitor. OBSERVATIONS: A 54-year-old female patient with endometrial cancer presented with CRVO and cystoid macular edema while receiving lenvatinib/pembrol...

Descripción completa

Detalles Bibliográficos
Autores principales: Foulsham, William, Edghill, Benjeil Z., Julia Canestraro, O.D., Makker, Vicky, Konner, Jason, Abramson, David H., Francis, Jasmine H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284313/
https://www.ncbi.nlm.nih.gov/pubmed/35845747
http://dx.doi.org/10.1016/j.ajoc.2022.101657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284313/
https://www.ncbi.nlm.nih.gov/pubmed/35845747
http://dx.doi.org/10.1016/j.ajoc.2022.101657

Ejemplares similares